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Fig. S1. The CDP-Etn pathway is required for somatic cell reprogramming. Fig. S2 . Characterization of iPSCs generated from iCD1 or ΔiCD1 and generation of Pcyt2 knockout mESCs. Fig. S3 . The CDP-Etn pathway acceleration of MET depends on Pebp1. Fig. S4 . The CDP-Etn-Pebp1 axis modulates NF-κB signaling to inhibit mesenchymal genes. Table S1 . Lipid species identified MEFs, mESCs, and MEFs undergoing SKO reprogramming on days 2, 4, 6, and 8. Table S2 . shRNA target sequences. Table S3 . Primers for qRT-PCR. Table S4 . Primers for ChIP-qPCR. reprogramming was sufficient to achieve optimal reprogramming efficiency. The numbers of
Oct4-GFP + colonies were counted on day 6 in MEFs transduced with SKO in ΔiCD1 medium supplemented with Etn during different time frames as indicated. Data are represented as mean ± SD, n=3. **P<0.01, ***P<0.001. (J) Etn had no effect on reprogramming when Etnk1/2 or Pcyt2 was blocked by shRNAs. The numbers of Oct4-GFP + colonies were counted on day 6. shLuc was used as control. Data are represented as mean ± SD, n=3. ***P<0.001. 
